Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05655494 · ClinicalTrials.gov registry record
A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials
A clinical trial of Cancer, sponsored by University of Florida.
- Recruiting
- Registry status
- 350
- Enrollment target
- 3
- Study locations
NCT05655494 is a study of Cancer that is actively recruiting participants, run by University of Florida. The registered enrollment target is 350 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (90% lower). The trial reports 3 study locations across 1 state.
The verdict
NCT05655494, a study of Cancer, is actively recruiting participants, sponsored by University of Florida.
- RECRUITING
- Registry status
- 350 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this study is to pilot test and evaluate an existing tailored ALEX (Agent Leveraging Empathy for eXams) Research Portal to navigate Black and Hispanic adult cancer patients and their family members through referral to cancer clinical trials.
Conditions Studied
Interventions
- BEHAVIORAL Stand-alone Research Portal
- BEHAVIORAL Portal with Virtual Community Health Educator (vCHE)
Study Locations (3)
Florida
- University of Florida - Gainesville
- Mayo Clinic in Florida - Jacksonville
- University of Miami - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 350 participants |
| Start Date | 2025-05-20 |
| Est. Completion | 2027-08-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05655494
The ClinicalTrials.gov registry entry for NCT05655494 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 350 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (90% lower). The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 2 interventions - of which Stand-alone Research Portal is the first listed.
NCT05655494 reports 3 study locations spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT05655494 about?
NCT05655494 is a clinical study titled "A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials". The purpose of this study is to pilot test and evaluate an existing tailored ALEX (Agent Leveraging Empathy for eXams) Research Portal to navigate Black and Hispanic adult cancer patients and their family members through referral to cancer clinical trials.
What is the current status of trial NCT05655494?
This trial is currently recruiting. The enrollment target is 350 participants. The study started on 2025-05-20. Estimated completion is 2027-08-31.
What conditions does trial NCT05655494 study?
This clinical trial studies the following conditions: Cancer.
What interventions are being tested in trial NCT05655494?
The interventions under investigation include: Stand-alone Research Portal (BEHAVIORAL), Portal with Virtual Community Health Educator (vCHE) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05655494?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05655494 being conducted?
This trial has 3 study locations across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated with Radiation
RECRUITING
-
Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
RECRUITING · Phase 2
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
RECRUITING · Phase 1
-
Long-Term Follow-Up of Recipient of Gene Transfer Research
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.